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Abstract
Background: The zebrafish, Danio rerio, possesses the paralogous genes aplnra and aplnrb that are
duplicates of an ancestral orthologue of the human APLNR gene encoding a G-protein coupled
receptor that binds the peptide ligand APELIN and is required for normal cardiovascular function.
aplnrb is required for migration of cells contributing to heart development in zebrafish embryos.
aplnra  is transcribed in a complex pattern during early development but its function in
embryogenesis is largely unknown.
Findings: Blockage of translation of aplnra mRNA in zebrafish embryos results in retarded or failed
epiboly with the blastoderm apparently disconnected from the nuclei of the yolk syncytial layer.
Gastrulation is also defective. Failure of correct tail extension is observed with ectopic structures
resembling somites positioned dorsal to the spinal cord.
Conclusion:  aplnra, unlike its duplicate aplnrb, is essential for normal epiboly, although this
function appears to be independent of signalling activated by zebrafish Apelin. The defects in epiboly
caused by loss of aplnra activity appear, at least partially, to be due to a requirement for aplnra
activity in the yolk syncytial layer.
Background
The human gene APLNR  (formerly named AGTRL1)
encodes a G protein-coupled receptor related to the angi-
otensin receptors. Investigation in a variety of model sys-
tems has shown that APLNR has roles in both
development of the blood vasculature and the heart [1-5]
and in regulation of cardiovascular function, e.g. as a
potent stimulator of cardiac contractility [6]. It also func-
tions as an arterial and venous dilator [7]. APLNR has also
been of interest as a receptor for the Human Immunode-
ficiency Virus, [8].
The zebrafish genes aplnra (formerly agtrl1a) and aplnrb
(formerly agtrl1b) are paralogous genes derived by dupli-
cation of an ancestral teleost orthologue of human
APLNR. aplnrb has been shown to be essential for the ear-
liest moments of heart morphogensis (the formation of
myocardial progenitors in the heart field and their subse-
quent migration) and for cell movements during gastrula-
tion [4,5]. These two genes appear to have somewhat
redundant functions in formation of cardiomyocytes [4].
aplnra and aplnrb are transcribed in similar patterns during
epiboly and gastrulation suggesting that they may also
both play roles in controlling these processes [4,5,9].
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While loss of Aplnrb protein expression causes defects in
gastrulation, no role in epiboly has been observed.
The ligand for human APLNR protein is a short peptide,
APELIN (reviewed by [10]), for which a zebrafish ortho-
logue exists encoded by the gene apln. Zeng et al. [5]
detected apln transcripts (by RT-PCR) first during develop-
ment after commencement of gastrulation. By mid-gastru-
lation, apln transcripts can be detected in the notochord
by whole mount in situ transcript hybridisation. This
argues against a role for zebrafish Apelin-Aplnra/b signal-
ling in epiboly. However, ectopic and early expression of
apln mRNA by mRNA injection does produce defects in
epiboly [5] suggesting that inappropriate activation of
Aplnra/b receptors might interfere with this morphologi-
cal movement.
Materials and methods
The work was carried out under the auspices of the Animal
Ethics and Institutional Biosafety Committees of the Uni-
versity of Adelaide.
Morpholino (MO) oligonucleotides were obtained from
Gene Tools (LLC, Corvallis, OR, USA). Three aplnra-MOs
binding to non-overlapping sequences on aplnra mRNA
to block translation were designed as follows:
(MO1) 5'-GTGTATTCCGACGTTGGCTCCATTT-3'
(MO2) 5'-TTGAGTCCTTCTTGAGCAGTTTATC-3'
(MO3) 5'-AATGTTTGGATTCTTCTGTCTGATA-3'.
The standard negative control MO sequence (Cont MO),
also from Gene Tools, had the sequence: 5'-CCTCTTAC-
CTCAGTTACAATTTATA-3'. Rescue of the phenotype gen-
erated by MO3 injection was demonstrated by injection of
this MO at the 1-cell stage followed by injection of aplnra
mRNA (see later) that had been engineered to lack the
MO3-binding site and to contain an optimal Kozak's
sequence (5'-GCCAGGATG-3', bold indicates start
codon). This mRNA was transcribed from the pCS2+
expression vector containing the aplnra  open reading
frame using the mMessage mMachine kit (Ambion Inc.,
Austin, TX, USA). 2-5 nL of morpholino or mRNA were
injected per embryo. MO and mRNA injections, [11] and
whole mount in situ transcript hybridisation, [12], were
performed essentially as previously described.
To visualise migration of YSL nuclei relative to the blasto-
derm margin during epiboly, embryos injected with Cont
MO or MO3 were subsequently injected with 1 nL of 0.5
mM Sytox Green fluorescent nucleic acid dye (Molecular
Probes®, Invitrogen, Life Technologies Corp. Carlsbad, Ca,
USA) into the yolk cell at the sphere stage (4 hours post
fertilisation @ 28.5°C, hpf) and then visualised at 6-8 hpf
under both epifluorescence and bright field optics using a
Zeiss AxioImager Z.1 with ApoTome attachment. Images
were captured and processed using a Zeiss AxioCam MR
and AxioVision 4.5 software (Carl Zeiss MicroImaging
GmbH, Jena, Germany).
Results and Discussion
Aplnra is required for normal epiboly
To test the effects on development of loss of Aplnra pro-
tein activity we designed three antisense MO oligonucle-
otides (MO1, MO2, MO3) complementary to non-
overlapping regions of the 5' untranslated region or trans-
lational start region of aplnra mRNA. Injection of each of
these MOs into 1 cell-stage embryos resulted in complete
or partial failure of epiboly in a concentration dependent
manner (Table 1; Figure 1J). In these embryos, cleavage
and blastula stages appeared normal, but by the onset of
gastrulation, a slight retardation of epiboly was evident.
This delay subsequently increased relative to negative con-
trol MO (Cont MO)-injected embryos such that when
control embryos had completed epiboly (bud stage, Fig-
ure 1J), the vegetal progress of the gastrula margin of
aplnra-MO injected embryos was frequently stalled prior
to yolk plug closure at the 75% position (Figure 1J and
arrowheads in Figure 1A). Nevertheless, at this stage, the
head process had migrated to an essentially wildtype posi-
tion at the animal pole (asterisk, Figure 1A). Many of the
stalled embryos subsequently burst their vegetal yolk
cells, leading to death (data not shown). By the time that
control siblings reached the 10 somite stage (Figure 1K),
aplnra MO-injected embryos that had completed epiboly
showed a concentration-dependent delay in tailbud for-
mation and posterior extension, and concentration-
dependent severity of defects in these processes. This led
to a failure in tail and yolk extension eversion and out-
growth, when assayed at 24 hpf (Figure 1L, and compare
H and I).
In contrast to the striking defective epiboly phenotypes
seen with the aplnra-targeted MOs, injection of Cont MO
at the highest of these concentrations (1.0 mM) produced
a very low level of defects (Figure 1J-L, Table 1). Further-
more, injection of MO3 at the 1-cell stage followed by
injection into the yolk cell of an aplnra mRNA engineered
to lack MO3's binding site led to effective rescue of the
epiboly phenotype (described later). We also examined
whether the failure to undergo posterior extension might
be caused by cell death in the tailbud. Acridine orange
staining of aplnra-injected embryos revealed a slight
increase in the number of dying cells with elevated levels
found primarily in the head (asterisk, Figure 1I) relative to
Cont MO-injected siblings (Figure 1H). Combined, these
data support that the defective epiboly phenotype is a spe-
cific effect of reducing the translation of endogenousBMC Research Notes 2009, 2:231 http://www.biomedcentral.com/1756-0500/2/231
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aplnra mRNA, indicating a role for this gene in the regula-
tion of epiboly.
aplnra  is expressed in the yolk syncytial layer and the
enveloping layer (EVL) [9]. Microtubules within the YSL
are required to drive normal epibolic movement and this
is achieved through correct connections with the EVL. The
published data on aplnrb  expression are insufficient to
determine whether this gene is also expressed in the YSL
and EVL. During early epiboly, aplnra is also expressed in
deep cells [9]. At the 32-cell stage, central blastomeres no
longer have cytoplasmic connections to the yolk cell [13].
If a MO was injected into the yolk at the 32-cell stage, its
distribution would be restricted mainly to the YSL and
marginal blastomeres and, at later stages, many cells of
the embryo proper would possess no or a lower concen-
tration of the MO. When MO2 was injected into the yolk
cell at the 32-cell stage, the embryos still showed defects
in epiboly but, in those embryos that managed to com-
plete epiboly, there was a decrease in tail extension
defects. This supports that the tail extension defects are
primarily due to lack of aplnra function in the embryo
proper (Table 1).
We were unable to rescue epiboly defects in MO3-injected
embryos when both MO3 and aplnra mRNA (engineered
to lack the MO3-binding site) were injected into the
embryo at the one cell stage (data not shown). However,
we observed a highly statistically significant decrease in
epiboly defects when MO3 was injected at the 1-cell stage
followed by aplnra  mRNA injection into the yolk cell
immediately vegetal to the embryo at the 32-cell stage
(Table 2). The failure of mRNA injection to rescue devel-
opment when this was performed at the 1-cell stage but
success after injection at the 32-cell stage may reflect insta-
bility of injected mRNA and/or its protein product result-
ing in failure to provide sufficiently high concentrations
of  aplnra  activity at the required developmental stage.
Another possibility is that injection of mRNA into the
yolk cell immediately vegetal to the embryo at the 32-cell
stage provides greater aplnra activity in the YSL compared
to when mRNA is injected into the embryo proper at the
1-cell stage. This is because mRNA injected into zebrafish
embryos has a much lesser tendency to spread than MO
oligonucleotides as demonstrated by the frequently uni-
lateral function of mRNA when injected into one cell of a
2-cell stage embryo (e.g. [14]). The result above supports
that aplnra activity in the YSL is important for normal epi-
boly in zebrafish.
Loss of aplnra  function by injection of MO3 results in
decoupling of YSL nuclei from the blastoderm margin as
demonstrated by labelling of YSL nuclei with Sytox Green
dye (Figure 1F, G). Note that we are unable to state
whether this uncoupling is due to loss of aplnra function
in the YSL, the EVL or both since we have not examined
the behaviour of the EVL when aplnra activity is lost.
Aplnra is required for normal cell movement during 
gastrulation
Close examination of the gastrula margin and presump-
tive notochord in aplnra MO-injected embryos using the
transcription of tbx16  to highlight these structures
revealed several types of disruption (Figure 1A-C). Firstly,
the margin was often uneven near the shield, with groups
of cells apparently displaced animally from their neigh-
Phenotypic effects of blocking translation of aplnra mRNA Figure 1 (see previous page)
Phenotypic effects of blocking translation of aplnra mRNA. A-C: Lateral (A) and dorsal axial views (B, C) of a repre-
sentative embryo at 75% epiboly injected with MO oligonucleotide inhibiting translation of aplnra mRNA. Anterior is up. This 
embryo is stained to show cells transcribing tbx16 in order to reveal paraxial presomitic mesoderm. The position of the 
arrested epibolic margin is indicated by arrowheads in A. Note the presence of tbx16-expressing cells in the axis (white arrows 
in B, enlarged in C), and apparently scattered in the hypoblast (arrowheads in B), and notches in the margin (asterices in B, 
C). D-E: Ectopic structures resembling somites (es) in the retarded tails of embryos with reduced aplnra mRNA translation 
but that complete epiboly. These ectopic structures are clearly seen in a lateral view (E, anterior to top, dorsal to right). The 
yolk extension (ye) and chorion (ch) are indicated. A transverse optical section of the tail tip shows ectopic structures resem-
bling somites (es) dorsal to the spinal cord (D). F-G: YSL nuclei, labelled with Sytox Green dye (white dots) move vegetally 
with the blastoderm margin in an embryo injected with Cont MO at 1 mM (F) but move ahead of the margin in an embryo 
injected with MO3 at 1 mM (G). Yellow dashed lines indicate the position of the blastoderm margin. Embryos are oriented 
with animal pole to top. Each image is a composite of images captured under epifluorescence and bright field illumination. H-I: 
Acridine orange staining of a Cont MO-injected embryo (H) and an embryo injected with MO3 at 1 mM at the 1-cell stage (I). 
The latter embryo shows a slightly higher level of apoptosis, primarily in the head (asterisk). Note the retarded tail formation. 
Anterior is left and dorsal is up. J-L: Embryos were injected with Cont MO at 1 mM or with a series of MO2 concentrations (1 
mM, 0.5 mM, 0.25 mM) blocking aplnra mRNA translation at the one cell stage or into the animal pole of the yolk cell at the 32-
cell stage (1 mM yolk injection). The injected embryos were observed at 8 (a), 14 (b) and 24 hpf (c) and assessed for the 
extent to which they had undergone epiboly and, if they completed epiboly, for the length of their tail extension. Developmen-
tal stage descriptors under the histograms refer only to epiboly or tail extension relative to that of a wild type embryo at 
28.5°C. Size bars are 100 μm except for D, E, 50 μm.BMC Research Notes 2009, 2:231 http://www.biomedcentral.com/1756-0500/2/231
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bours (asterices, Figure 1B, C). These "notches" in the
margin have previously been seen in cdh1 (hab) mutants
[15], suggesting a problem with cell adhesion. Secondly,
isolated, scattered tbx16 positive cells were seen in the
hypoblast animal to the marginal expression domain
(arrowheads, Figure 1B). Thirdly, although the shield and
notochord/spinal cord primordia are normally devoid of
tbx16 expressing cells, in aplnra-deficient embryos multi-
ple tbx16 positive cells were found in this domain (arrows,
Figure 1B, C). Zeng et al. [5] showed that apelin  is
expressed in the notochord during gastrulation and both
aplnra [9] and aplnrb [5] are expressed in the epithelial
adaxial cells that flank this structure. Thus, the loss of
aplnra expression appears to allow either mixing of axial
and adaxial cells or inappropriate differentiation of cells
within axial structures. Furthermore, in many of the
embryos surviving to tail extension stages, structures
resembling somites were observed lying dorsal to the CNS
(Figure 1D, E). These observations of aberrant positioning
Table 1: aplnra function is required for normal epiboly and elongation/extension movements
%
Age (normal developmental stage) Apparent Developmental Stagea ABCD C o n t r o l
8 hpf (75% epiboly) 7 5 %  e p i b o l y - b u d 1 11 02 76 5 8 0
5 0 % - 7 5 %  e p i b o l y 6 67 57 02 8 1 6
30%-50% epiboly 23 14 3 8 4
(n) = (96) (69) (60) (65) (48)
14 hpf (10 somite) 10 somite stage+ 22 3 10 18 87
6-10 somite stage 8 17 24 71 6
bud-6 somite stage 25 59 37 3 2
75% epiboly-bud 20 13 18 3 2
50% - 75% epiboly 10 6 8 3 2
30%-50% epiboly 15 2 3 2 1
(n) = (61) (57) (62) (65) (46)
24 hpf (prim-5) 24 hpf+ 7 2 13 66 88
18-24 hpf 48 3 27 19 9
b u d - 1 8  h p f 2 78 13 31 1 2
75% epiboly-bud 6 11 11 0 1
5 0 %  -  7 5 %  e p i b o l y 4 31 13 0
30%-50% epiboly 7 0 6 2 0
(n) = (67) (63) (64) (64) (45)
Ectopic Cell Massb 67 84 17 4 1
Injection of MO2 at different concentrations results in different levels of developmental delay in terms of epiboly and elongation/extension. 
Injection of MO2 at later developmental stages (into yolk cell vegetal to embryo at 32-cell stage, partially restricting localisation of MO2 to the YSL) 
leads to similar, if slightly reduced, levels of delay as found in embryos injected at the 1-cell stage. This indicates that aplnra has critical functions 
primarily in the YSL. A = 1 mM MO2 injection at 32 cell stage (animal pole of the yolk), B = 1 mM MO2 injection at 1 cell stage, C = 0.50 mM MO2 
injection at 1 cell stage, D = 0.25 mM MO2 injection at 1 cell stage, Control = 1 mM MOCont injection at 1 cell stage. Notes: a As determined by 
extent of epiboly or extension/elongation. b Ectopic cell mass located dorsally to the early tail-bud/origin of the yolk extension, depending on 
apparent developmental stage. Represented as % of the total number of embryos injected (24 hpf).
Table 2: Rescue of the aplnra MO epiboly phenotype by co-
injection of aplnra mRNA
Extent of epiboly at 8 hpf MO3 alone MO3 + mRNA
% (n) % (n)
75% epiboly - bud 4.8 (7) 21 (30)
50-75% epiboly 49.0 (71) 52.4 (75)
30-50% epiboly 46.2 (67) 26.6 (38)
Total number injected (n) (145) (143)
MO3 at 1 mM was injected into the embryos at the 1-cell stage. aplnra 
mRNA at 100 ng/μL was injected into the yolk cell immediately 
vegetal to the embryo at the 32-cell stage. A contingency χ2 test of 
the data across all the phenotypic classes gives p < 0.001.Publish with BioMed Central    and   every 
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of cells of possible paraxial origin strongly suggest that
multiple cell movements are affected by reduction of
aplnra function.
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pholino; YSL: yolk syncytial layer.
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